Skip to main content
. 2020 Sep 12;47(2):465–473. doi: 10.1093/schbul/sbaa130

Table 3.

Incremental cost-effectiveness ratios (ICERs), differences in costs, and differences in months in remission, by type of symptom, with bootstrapped CIs

Value 95% CI
Additional month in total remission
 ICER, $/month $1627 Undefined $40 682
 Cost difference, $ $4112 $7790 $15 078
 Difference in number of months 2.5 −0.9 5.8
Additional month in positive remission
 ICER, $/month $614 Cost-saving $2751
 Cost difference, $ $4112 $7059 $15 122
 Difference in number of months 6.70 3.60 9.63
Additional month in negative remission
 ICER, $/month $1247 Undefined $16 776
 Cost difference, $ $4112 $7349 $14 988
 Difference in number of months 3.3 −0.2 6.6